Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for BRCA Testing

被引:6
作者
Farolfi, Alberto [1 ]
Lorusso, Domenica [2 ]
Pignata, Sandro [3 ]
De Giorgi, Ugo [1 ]
机构
[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy
[2] Fdn Policlin Univ Agostino Gemelli, IRCCS, Rome, Italy
[3] Fdn G Pascale, IRCCS, Ist Nazl Tumori, Naples, Italy
关键词
MUTATIONS;
D O I
10.1200/JCO.19.02055
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:172 / +
页数:3
相关论文
共 10 条
[1]   Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score) [J].
Bigot, Frederic ;
Castanon, Eduardo ;
Baldini, Capucine ;
Hollebecque, Antoine ;
Calmona, Alberto ;
Postel-Vinay, Sophie ;
Angevin, Eric ;
Armand, Jean-Pierre ;
Ribrag, Vincent ;
Aspeslagh, Sandrine ;
Varga, Andrea ;
Bahleda, Rastislav ;
Menis, Jessica ;
Gazzah, Anas ;
Michot, Jean-Marie ;
Marabelle, Aurelien ;
Soria, Jean-Charles ;
Massard, Christophe .
EUROPEAN JOURNAL OF CANCER, 2017, 84 :212-218
[2]   Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer [J].
Burger, Robert A. ;
Brady, Mark F. ;
Bookman, Michael A. ;
Fleming, Gini F. ;
Monk, Bradley J. ;
Huang, Helen ;
Mannel, Robert S. ;
Homesley, Howard D. ;
Fowler, Jeffrey ;
Greer, Benjamin E. ;
Boente, Matthew ;
Birrer, Michael J. ;
Liang, Sharon X. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) :2473-2483
[3]   Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer [J].
Dirican, Nigar ;
Karakaya, Yeliz Arman ;
Gunes, Sedat ;
Daloglu, Ferah Tuncel ;
Dirican, Ahmet .
CLINICAL RESPIRATORY JOURNAL, 2017, 11 (06) :789-796
[4]   Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24) [J].
Farolfi, Alberto ;
Petrone, Micaela ;
Scarpi, Emanuela ;
Galla, Valentina ;
Greco, Filippo ;
Casanova, Claudia ;
Longo, Lucia ;
Cormio, Gennaro ;
Orditura, Michele ;
Bologna, Alessandra ;
Zavallone, Laura ;
Ventriglia, Jole ;
Franzese, Elisena ;
Loizzi, Vera ;
Giardina, Donatella ;
Pigozzi, Eva ;
Cioffi, Raffaella ;
Pignata, Sandro ;
Giorda, Giorgio ;
De Giorgi, Ugo .
TARGETED ONCOLOGY, 2018, 13 (04) :469-479
[5]   BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study [J].
Harter, Philipp ;
Johnson, Toby ;
Berton-Rigaud, Dominique ;
Park, Sang-Yoon ;
Friedlander, Michael ;
del Campo, Josep M. ;
Shimada, Muneaki ;
Forget, Frederic ;
Mirza, Mansoor R. ;
Colombo, Nicoletta ;
Zamagni, Claudio ;
Chan, John K. ;
Imhof, Martin ;
Herzog, Thomas J. ;
O'Donnell, Dearbhaile ;
Heitz, Florian ;
King, Karen ;
Stinnett, Sandy ;
Barrett, Catherine ;
Jobanputra, Minesh ;
Xu, Chun-Fang ;
du Bois, Andreas .
GYNECOLOGIC ONCOLOGY, 2016, 140 (03) :443-449
[6]   BRCA1 plays a role in the hypoxic response by regulating HIF-1α stability and by modulating vascular endothelial growth factor expression [J].
Kang, HJ ;
Kim, HJ ;
Rih, JK ;
Mattson, TL ;
Kim, KW ;
Cho, CH ;
Isaacs, JS ;
Bae, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (19) :13047-13056
[7]  
MIRZA MR, 2019, J CLIN ONCOL S, V37
[8]   New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer [J].
Nelson, Brad H. .
CURRENT OPINION IN IMMUNOLOGY, 2015, 33 :93-100
[9]   Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study [J].
Norquist, Barbara M. ;
Brady, Mark F. ;
Harrell, Maria I. ;
Walsh, Tom ;
Lee, Ming K. ;
Gulsuner, Suleyman ;
Bernards, Sarah S. ;
Casadei, Silvia ;
Burger, Robert A. ;
Tewari, Krishnansu S. ;
Backes, Floor ;
Mannel, Robert S. ;
Glaser, Gretchen ;
Bailey, Cheryl ;
Rubin, Stephen ;
Soper, John ;
Lankes, Heather A. ;
Ramirez, Nilsa C. ;
King, Mary Claire ;
Birrer, Michael J. ;
Swisher, Elizabeth M. .
CLINICAL CANCER RESEARCH, 2018, 24 (04) :777-783
[10]   Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer [J].
Tewari, Krishnansu S. ;
Burger, Robert A. ;
Enserro, Danielle ;
Norquist, Barbara M. ;
Swisher, Elizabeth M. ;
Brady, Mark F. ;
Bookman, Michael A. ;
Fleming, Gini F. ;
Huang, Helen ;
Homesley, Howard D. ;
Fowler, Jeffrey M. ;
Greer, Benjamin E. ;
Boente, Matthew ;
Liang, Sharon X. ;
Ye, Chenglin ;
Bais, Carlos ;
Randall, Leslie M. ;
Chan, John K. ;
Ferriss, J. Stuart ;
Coleman, Robert L. ;
Aghajanian, Carol ;
Herzog, Thomas J. ;
DiSaia, Philip J. ;
Copeland, Larry J. ;
Mannel, Robert S. ;
Birrer, Michael J. ;
Monk, Bradley J. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (26) :2317-+